Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents

Hanping Wu, Nicolas G. Rognin, Tianyi M. Krupka, Luis Solorio, Hiroki Yoshiara, Gilles Guenette, Christopher Sanders, Naohisa Kamiyama, Agata A. Exner

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

In contrast to the clinically used microbubble ultrasound contrast agents, nanoscale bubbles (or nanobubbles) may potentially extravasate into tumors that exhibit more permeable vasculature, facilitating targeted molecular imaging and drug delivery. Our group recently presented a simple strategy using the non-ionic surfactant Pluronic as a size control excipient to produce nanobubbles with a mean diameter of 200nm that exhibited stability and echogenicity on par with microbubbles. The objective of this study was to carry out an in-depth characterization of nanobubble properties as compared with Definity microbubbles, both invitro and invivo. Through use of a tissue-mimicking phantom, invitro experiments measured the echogenicity of the contrast agent solutions and the contrast agent dissolution rate over time. Nanobubbles were found to be more echogenic than Definity microbubbles at three different harmonic frequencies (8, 6.2 and 3.5MHz). Definity microbubbles also dissolved 1.67 times faster than nanobubbles. Pharmacokinetic studies were then performed invivo in a subcutaneous human colorectal adenocarcinoma (LS174T) in mice. The peak enhancement and decay rates of contrast agents after bolus injection in the liver, kidney and tumor were analyzed. No significant differences were observed in peak enhancement between the nanobubble and Definity groups in the three tested regions (tumor, liver and kidney). However, the decay rates of nanobubbles in tumor and kidney were significantly slower than those of Definity in the first 200-s fast initial phase. There were no significant differences in the decay rates in the liver in the initial phase or in three regions of interest in the terminal phase. Our results suggest that the stability and acoustic properties of the new nanobubble contrast agents are superior to those of the clinically used Definity microbubbles. The slower washout of nanobubbles in tumors suggests potential entrapment of the bubbles within the tumor parenchyma.

Original languageEnglish
Pages (from-to)2137-2146
Number of pages10
JournalUltrasound in Medicine and Biology
Volume39
Issue number11
DOIs
Publication statusPublished - Nov 2013
Externally publishedYes

Fingerprint

Microbubbles
Acoustics
Contrast Media
tumors
Pharmacokinetics
acoustics
kidneys
liver
decay rates
Neoplasms
Kidney
Liver
bubbles
Poloxamer
Molecular Imaging
fallout
entrapment
augmentation
acoustic properties
Excipients

Keywords

  • Cancer
  • Nanobubble
  • Pharmacokinetic study
  • Ultrasound contrast agents

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Biophysics

Cite this

Wu, H., Rognin, N. G., Krupka, T. M., Solorio, L., Yoshiara, H., Guenette, G., ... Exner, A. A. (2013). Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. Ultrasound in Medicine and Biology, 39(11), 2137-2146. https://doi.org/10.1016/j.ultrasmedbio.2013.05.007

Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. / Wu, Hanping; Rognin, Nicolas G.; Krupka, Tianyi M.; Solorio, Luis; Yoshiara, Hiroki; Guenette, Gilles; Sanders, Christopher; Kamiyama, Naohisa; Exner, Agata A.

In: Ultrasound in Medicine and Biology, Vol. 39, No. 11, 11.2013, p. 2137-2146.

Research output: Contribution to journalArticle

Wu, H, Rognin, NG, Krupka, TM, Solorio, L, Yoshiara, H, Guenette, G, Sanders, C, Kamiyama, N & Exner, AA 2013, 'Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents', Ultrasound in Medicine and Biology, vol. 39, no. 11, pp. 2137-2146. https://doi.org/10.1016/j.ultrasmedbio.2013.05.007
Wu, Hanping ; Rognin, Nicolas G. ; Krupka, Tianyi M. ; Solorio, Luis ; Yoshiara, Hiroki ; Guenette, Gilles ; Sanders, Christopher ; Kamiyama, Naohisa ; Exner, Agata A. / Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. In: Ultrasound in Medicine and Biology. 2013 ; Vol. 39, No. 11. pp. 2137-2146.
@article{87d29ef808c2494dbc36377864a07546,
title = "Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents",
abstract = "In contrast to the clinically used microbubble ultrasound contrast agents, nanoscale bubbles (or nanobubbles) may potentially extravasate into tumors that exhibit more permeable vasculature, facilitating targeted molecular imaging and drug delivery. Our group recently presented a simple strategy using the non-ionic surfactant Pluronic as a size control excipient to produce nanobubbles with a mean diameter of 200nm that exhibited stability and echogenicity on par with microbubbles. The objective of this study was to carry out an in-depth characterization of nanobubble properties as compared with Definity microbubbles, both invitro and invivo. Through use of a tissue-mimicking phantom, invitro experiments measured the echogenicity of the contrast agent solutions and the contrast agent dissolution rate over time. Nanobubbles were found to be more echogenic than Definity microbubbles at three different harmonic frequencies (8, 6.2 and 3.5MHz). Definity microbubbles also dissolved 1.67 times faster than nanobubbles. Pharmacokinetic studies were then performed invivo in a subcutaneous human colorectal adenocarcinoma (LS174T) in mice. The peak enhancement and decay rates of contrast agents after bolus injection in the liver, kidney and tumor were analyzed. No significant differences were observed in peak enhancement between the nanobubble and Definity groups in the three tested regions (tumor, liver and kidney). However, the decay rates of nanobubbles in tumor and kidney were significantly slower than those of Definity in the first 200-s fast initial phase. There were no significant differences in the decay rates in the liver in the initial phase or in three regions of interest in the terminal phase. Our results suggest that the stability and acoustic properties of the new nanobubble contrast agents are superior to those of the clinically used Definity microbubbles. The slower washout of nanobubbles in tumors suggests potential entrapment of the bubbles within the tumor parenchyma.",
keywords = "Cancer, Nanobubble, Pharmacokinetic study, Ultrasound contrast agents",
author = "Hanping Wu and Rognin, {Nicolas G.} and Krupka, {Tianyi M.} and Luis Solorio and Hiroki Yoshiara and Gilles Guenette and Christopher Sanders and Naohisa Kamiyama and Exner, {Agata A.}",
year = "2013",
month = "11",
doi = "10.1016/j.ultrasmedbio.2013.05.007",
language = "English",
volume = "39",
pages = "2137--2146",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents

AU - Wu, Hanping

AU - Rognin, Nicolas G.

AU - Krupka, Tianyi M.

AU - Solorio, Luis

AU - Yoshiara, Hiroki

AU - Guenette, Gilles

AU - Sanders, Christopher

AU - Kamiyama, Naohisa

AU - Exner, Agata A.

PY - 2013/11

Y1 - 2013/11

N2 - In contrast to the clinically used microbubble ultrasound contrast agents, nanoscale bubbles (or nanobubbles) may potentially extravasate into tumors that exhibit more permeable vasculature, facilitating targeted molecular imaging and drug delivery. Our group recently presented a simple strategy using the non-ionic surfactant Pluronic as a size control excipient to produce nanobubbles with a mean diameter of 200nm that exhibited stability and echogenicity on par with microbubbles. The objective of this study was to carry out an in-depth characterization of nanobubble properties as compared with Definity microbubbles, both invitro and invivo. Through use of a tissue-mimicking phantom, invitro experiments measured the echogenicity of the contrast agent solutions and the contrast agent dissolution rate over time. Nanobubbles were found to be more echogenic than Definity microbubbles at three different harmonic frequencies (8, 6.2 and 3.5MHz). Definity microbubbles also dissolved 1.67 times faster than nanobubbles. Pharmacokinetic studies were then performed invivo in a subcutaneous human colorectal adenocarcinoma (LS174T) in mice. The peak enhancement and decay rates of contrast agents after bolus injection in the liver, kidney and tumor were analyzed. No significant differences were observed in peak enhancement between the nanobubble and Definity groups in the three tested regions (tumor, liver and kidney). However, the decay rates of nanobubbles in tumor and kidney were significantly slower than those of Definity in the first 200-s fast initial phase. There were no significant differences in the decay rates in the liver in the initial phase or in three regions of interest in the terminal phase. Our results suggest that the stability and acoustic properties of the new nanobubble contrast agents are superior to those of the clinically used Definity microbubbles. The slower washout of nanobubbles in tumors suggests potential entrapment of the bubbles within the tumor parenchyma.

AB - In contrast to the clinically used microbubble ultrasound contrast agents, nanoscale bubbles (or nanobubbles) may potentially extravasate into tumors that exhibit more permeable vasculature, facilitating targeted molecular imaging and drug delivery. Our group recently presented a simple strategy using the non-ionic surfactant Pluronic as a size control excipient to produce nanobubbles with a mean diameter of 200nm that exhibited stability and echogenicity on par with microbubbles. The objective of this study was to carry out an in-depth characterization of nanobubble properties as compared with Definity microbubbles, both invitro and invivo. Through use of a tissue-mimicking phantom, invitro experiments measured the echogenicity of the contrast agent solutions and the contrast agent dissolution rate over time. Nanobubbles were found to be more echogenic than Definity microbubbles at three different harmonic frequencies (8, 6.2 and 3.5MHz). Definity microbubbles also dissolved 1.67 times faster than nanobubbles. Pharmacokinetic studies were then performed invivo in a subcutaneous human colorectal adenocarcinoma (LS174T) in mice. The peak enhancement and decay rates of contrast agents after bolus injection in the liver, kidney and tumor were analyzed. No significant differences were observed in peak enhancement between the nanobubble and Definity groups in the three tested regions (tumor, liver and kidney). However, the decay rates of nanobubbles in tumor and kidney were significantly slower than those of Definity in the first 200-s fast initial phase. There were no significant differences in the decay rates in the liver in the initial phase or in three regions of interest in the terminal phase. Our results suggest that the stability and acoustic properties of the new nanobubble contrast agents are superior to those of the clinically used Definity microbubbles. The slower washout of nanobubbles in tumors suggests potential entrapment of the bubbles within the tumor parenchyma.

KW - Cancer

KW - Nanobubble

KW - Pharmacokinetic study

KW - Ultrasound contrast agents

UR - http://www.scopus.com/inward/record.url?scp=84884534689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884534689&partnerID=8YFLogxK

U2 - 10.1016/j.ultrasmedbio.2013.05.007

DO - 10.1016/j.ultrasmedbio.2013.05.007

M3 - Article

C2 - 23932272

AN - SCOPUS:84884534689

VL - 39

SP - 2137

EP - 2146

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 11

ER -